Alzheimer’s may leave a mark on the brain long before plaques appear

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-02T15:12:07.536Z • Permanent link

Researchers from the University of California, Los Angeles (UCLA), in collaboration with the Alzheimer's Disease Cooperative Study (ADCS), have made a groundbreaking discovery that could revolutionize our understanding of the disease. Led by Dr. David Reed, the team tracked the brain changes associated with Alzheimer's in healthy older adults over nearly 20 years. The study, published in the journal Neurology, used advanced brain imaging techniques to detect subtle changes in brain structure and function. The researchers found that these changes may begin at least seven years before amyloid plaques become detectable with current PET scans. The findings suggest that early detection and intervention may be possible, potentially altering the course of the disease.

The research team used a combination of magnetic resonance imaging (MRI) and positron emission tomography (PET) scans to monitor the brains of 111 healthy older adults over a period of 20 years. The scans were performed annually, and the data was analyzed to identify any changes in brain structure and function. The researchers also used advanced machine learning algorithms to detect subtle patterns in the data that may indicate the onset of Alzheimer's. The study's findings were confirmed by independent review by multiple experts in the field.

The study's results have significant implications for the development of new diagnostic tools and treatments for Alzheimer's. Dr. Reed and his team are now working with pharmaceutical companies to develop new therapies that can target the early stages of the disease. The study's findings also highlight the importance of long-term research and collaboration between academia, industry, and government. As Dr. Reed noted, "This study demonstrates the power of long-term research and the importance of collaboration in advancing our understanding of Alzheimer's disease.

The discovery of early brain changes associated with Alzheimer's has significant implications for the AI and tech ecosystem. Companies such as Google and Amazon are already working on AI-powered diagnostic tools that can detect the disease early. However, these tools are still in the experimental stage, and the current study's findings suggest that they may need to be revised. The researchers' discovery of early brain changes may also lead to the development of new treatments that can target the early stages of the disease, potentially altering the course of the disease.

The study's findings also have significant implications for the research community. The discovery of early brain changes associated with Alzheimer's may lead to a re-evaluation of current diagnostic tools and treatments. The researchers' use of advanced machine learning algorithms to detect subtle patterns in the data also highlights the potential for AI-powered diagnostics in the field. Companies such as IBM and Microsoft are already working on AI-powered diagnostic tools that can detect a range of diseases, including Alzheimer's.

The study's findings also have significant implications for the markets and policy environments surrounding Alzheimer's research. The development of new diagnostic tools and treatments is a significant investment, and the study's findings suggest that the returns may be substantial. Companies such as Pfizer and Johnson & Johnson are already investing heavily in Alzheimer's research, and the study's findings may lead to increased investment in the field.